0000000000199024

AUTHOR

M. Coppola

showing 6 related works from this author

Food web reconstruction gives evidence of increased trophic levels in no-trawl areas: the red mullet, Mullus barbatus L. case in northern Sicily

2018

This study was aimed at identifying the food web of the red mullet, Mullus barbatus in order to understand how it is affected by trawling disturbance. To achieve this objective: a) the main features of the red mullet habitat were investigated; b) the food web of this habitat was studied in two no-trawl areas and in two areas open to trawling. The working hypothesis is that trawling affects the biochemistry of the sediment and the trophic structure of the benthic assemblage. It was predicted: a) less biomass, smaller size and higher production rate in the benthic assemblages of protected gulfs; b) higher average trophic level for both the red mullet and its predators in protected gulfs; c) a…

Settore BIO/07 - EcologiaMullus barbatusFisheriefood webtrawl banstable isotopeimpactMediterranean SeapredationMediterraneanSicilyGulf of Castellammare
researchProduct

Movement pattern of spawners of white seabream, Diplodus sargus sargus (Linnaeus, 1758), in the gulf of Castellammare (NW Sicily)

2011

ultrasonic telemetry movement pattern white seabream spawning season Tyrrhenian Sea
researchProduct

Magnetic field driven enhancement of the weak decay width of charged pions

2020

We study the effect of a uniform magnetic field B→ on the decays π⁻ → l⁻ ν⁻l, where l⁻ = e⁻, μ⁻, carrying out a general analysis that includes four π⁻ decay constants. Taking the values of these constants from a chiral effective Nambu-Jona-Lasinio (NJL) model, it is seen that the total decay rate gets strongly increased with respect to the B = 0 case, with an enhancement factor ranging from ∼ 10 for eB = 0.1 GeV² up to ∼ 10³ for eB = 1 GeV². The ratio between electronic and muonic decays gets also enhanced, reaching a value of about 1 : 2 for eB = 1 GeV². In addition, we find that for large B the angular distribution of outgoing antineutrinos shows a significant suppression in the direction…

PhysicsNuclear and High Energy Physics010308 nuclear & particles physicsHigh Energy Physics - Lattice (hep-lat)FísicaFOS: Physical sciences//purl.org/becyt/ford/1.3 [https]QCD Phenomenology7. Clean energy01 natural sciencesMagnetic fieldNuclear physics//purl.org/becyt/ford/1 [https]High Energy Physics - PhenomenologyPionHigh Energy Physics - LatticeHigh Energy Physics - Phenomenology (hep-ph)0103 physical scienceslcsh:QC770-798lcsh:Nuclear and particle physics. Atomic energy. RadioactivityHigh Energy Physics::Experiment010306 general physicsCiencias Exactas
researchProduct

Neutral and charged pion properties under strong magnetic fields in the NJL model

2019

In the framework of the Nambu-Jona-Lasino (NJL) model, we study the effect of an intense external uniform magnetic field on neutral and charged pion masses and decay form factors. In particular, the treatment of charged pions is carried out on the basis of the Ritus eigenfunction approach to magnetized relativistic systems. Our analysis shows that in the presence of the magnetic field three and four nonvanishing pion-to-vacuum hadronic form factors can be obtained for the case of the neutral and charged pions, respectively. As expected, it is seen that for nonzero magnetic field the π⁰ meson can still be treated as a pseudo Nambu-Goldstone boson, and consequently the corresponding form fact…

Particle physicsMesonHigh Energy Physics::LatticeEffective field theoryHadronNuclear TheoryFOS: Physical sciences01 natural sciencesLeptonic semileptonic & radiative decaysHadronic decaysHigh Energy Physics - Phenomenology (hep-ph)Pion0103 physical sciencesNonperturbative effects in field theory010306 general physicsCiencias ExactasBosonPhysicsBasis (linear algebra)010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyForm factorsEigenfunctionMagnetic fieldHigh Energy Physics - PhenomenologyHigh Energy Physics::Experiment
researchProduct

Pruritus characteristics in a large Italian cohort of psoriatic patients

2019

Background: Psoriasis (Ps) is a chronic systemic autoimmune disease associated with pruritus in 64–98% of patients. However, few modestly sized studies assess factors associated with psoriatic pruritus. Objective: To investigate factors associated with Ps pruritus intensity. Methods: Psoriasis patients 18 years or older seen in one of 155 centres in Italy between September 2005 and 2009 were identified from the Italian PsoCare registry. Patients without cutaneous psoriasis and those with missed information on pruritus were excluded. Results: We identified 10 802 patients, with a mean age 48.8 ± 14.3 years. Mild itch was present in 33.2% of patients, moderate in 34.4%, severe in 18.7% and ve…

MaleCross-sectional studySeverity of Illness IndexCohort Studies030207 dermatology & venereal diseases0302 clinical medicineRisk Factorseducation; itch; pruritus; psoriasis; pustular psoriasis; treatment; Adolescent; Adult; Cohort Studies; Cross-Sectional Studies; Educational Status; Facial Dermatoses; Female; Foot Dermatoses; Genitalia; Hand Dermatoses; Humans; Italy; Male; Middle Aged; Pruritus; Psoriasis; Registries; Risk Factors; Severity of Illness Index; Sex Factors; Young AdultEpidemiologyitchRegistriesYoung adultskin and connective tissue diseaseseducationtreatmentMiddle AgedSettore MED/33 - MALATTIE APPARATO LOCOMOTOREInfectious Diseasespustular psoriasisItaly030220 oncology & carcinogenesisCohortEducational StatusPRURITIS EPIDEMIOLOGYFemaleSettore MED/35 - MALATTIE CUTANEE E VENEREECohort studyAdultmedicine.medical_specialtyAdolescentPSORIASDermatologyHand DermatosesArticle03 medical and health sciencesYoung AdultPharmacotherapySex FactorsSettore MED/35PsoriasisSeverity of illnessmedicineHumansPsoriasisGenitaliaFoot Dermatosesbusiness.industryPruritusmedicine.diseaseDermatologyPruritusItch sensationCross-Sectional StudiesbusinessFacial Dermatoses
researchProduct

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry

2014

Background: Some studies have shown that switching patients from one tumor necrosis factor (TNF)-alfa inhibitor to another may be beneficial when they have an inadequate response or an adverse event. Objective: We sought to assess the variables predicting the efficacy of the second TNF-alfa inhibitor in patients discontinuing the first TNF-alfa inhibitor. Methods: Data from all 5423 consecutive patients starting TNF-alfa inhibitor therapy for psoriasis between September 2005 and September 2010 who were included in the Italian Psocare registry were analyzed. Results: In 105 patients who switched to a second TNF-alfa inhibitor who had complete follow-up data, 75% improvement in the Psoriasis …

Maleprimary inefficacy75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitors; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young AdultSWITHCESefficacyTNFpsoriasis; psoriasis arthritis; pharmachological treatmentPASI 75Severity of Illness IndexReceptors Tumor Necrosis FactorEtanerceptCohort StudiesMonoclonalReceptorsSettore MED/35 - Malattie Cutanee E VenereeRegistriesHumanizedtumor necrosis factor-alfa inhibitors.switchingHazard ratioAntibodies MonoclonalMiddle AgedTreatment OutcomeItalyPredictive value of tests75% improvement in the Psoriasis Area Severity Index scoreFemaleDrugPsoriasis Area Severity IndexbiologicTNF-alphaAdultmedicine.medical_specialtytumor necrosis factorDermatology75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitorsAntibodies Monoclonal Humanizedsecondary loss of efficacyRisk AssessmentAntibodiestumor necrosis factor-alfa inhibitorsDrug Administration ScheduleDose-Response RelationshipYoung AdultSettore MED/35Predictive Value of TestsInternal medicinePsoriasisSeverity of illnessmedicineConfidence IntervalsHumansPsoriasisbiologicsAdverse effectPsoriasis; TNF-alphaProportional Hazards ModelsRetrospective Studiespsoriasibiologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor-alfa inhibitors; Adalimumab; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infliximab; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult; 2708Analysis of Variancepharmachological treatmentDose-Response Relationship DrugProportional hazards modelbusiness.industrytumor necrosis factor-alfa inhibitorTumor Necrosis Factor-alphaPASIAdalimumabRetrospective cohort studypsoriasis arthritismedicine.diseaseConfidence intervalInfliximabSurgeryImmunoglobulin GMultivariate AnalysisANTI-TNFAbusiness2708Follow-Up Studies
researchProduct